Change search
ReferencesLink to record
Permanent link

Direct link
The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs-A practical view
Umeå University, Faculty of Medicine, Department of Pharmacology and Clinical Neuroscience, Pharmacology.
2015 (English)In: European Neuropsychopharmacology, ISSN 0924-977X, E-ISSN 1873-7862, Vol. 25, no 6, 749-762 p.Article, review/survey (Refereed) Published
Abstract [en]

The endocannabinoid system, comprising cannabinoid CB1 and CB2 receptors, their endogenous ligands anandamide and 2-arachidonoylglyerol, and their synthetic and metabolic enzymes, are involved in many biological processes in the body, ranging from appetite to bone turnover. Compounds inhibiting the breakdown of anandamide and 2-arachidonoylglycerol increase brain levels of these lipids and thus modulate endocannabinoid signalling. In the present review, the preclinical evidence that these enzymes are good targets for development of novel therapies for anxiety and depression are discussed from a practical, rather than mechanistic, point of view. It is concluded that the preclinical data are promising, albeit tempered by problems of tolerance as well as effects upon learning and memory for irreversible monoacylglycerol lipase inhibitors, and limited by a focus upon male rodents alone. Clinical data so far has been restricted to safety studies with inhibitors of anandamide hydrolysis and a hitherto unpublished study on such a compound in elderly patients with major depressive disorders, but under the dose regimes used, they are well tolerated and show no signs of "cannabis-like" behaviours.

Place, publisher, year, edition, pages
2015. Vol. 25, no 6, 749-762 p.
Keyword [en]
Endocannabinoid, Fatty acid amide hydrolase, Monoacylglycerol lipase, Anxiety, Depression, Drug velopment
National Category
Neurology Neurosciences Pharmacology and Toxicology
URN: urn:nbn:se:umu:diva-106017DOI: 10.1016/j.euroneuro.2015.02.005ISI: 000356109400001OAI: diva2:840005
Available from: 2015-07-06 Created: 2015-07-03 Last updated: 2016-05-16Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Fowler, Christopher J.
By organisation
In the same journal
European Neuropsychopharmacology
NeurologyNeurosciencesPharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 42 hits
ReferencesLink to record
Permanent link

Direct link